High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

We evaluated high-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. One hundred and seventy-four consecutive patients who were at risk for CMV infection (either recipient or donor seropositive) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, R, Cortez, K, Solomon, S, Battiwalla, M, Gill, VJ, Hensel, N, Childs, R, Barrett, AJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091676/
https://www.ncbi.nlm.nih.gov/pubmed/12203140
http://dx.doi.org/10.1038/sj.bmt.1703648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091676/
https://www.ncbi.nlm.nih.gov/pubmed/12203140
http://dx.doi.org/10.1038/sj.bmt.1703648

Ejemplares similares